To confirm the mRNA expression levels of TARC/CCL17 and MDC/CCL22, which are known AD biomarkers, real-time PCR was performed by treating the HaCaT cell line that was stimulated with IFN-γ and TNF-α with the P. affinis extract. The gene discussed is CCL22; the disease is Alzheimer disease.